Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:41:02 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



Q:BSEM - BIOSTEM TECHNOLOGIES INC - https://www.biostemtechnologies.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BSEM - Qnot subscribed8.00-0.99-11.049.44092128.99  9.00  7.9615.50  1.20May 03Apr 3015 min RT 2¢

Recent Trades - Last 10 of 212
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-30 08:30U:BSEMNews ReleaseBioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
2024-04-25 08:00U:BSEMNews ReleaseBioStem Technologies to Present at the 2024 Planet MicroCap Showcase
2024-04-24 08:00U:BSEMNews ReleaseBioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
2024-04-02 08:00U:BSEMNews ReleaseBioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
2024-04-01 16:05U:BSEMNews ReleaseBioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
2024-03-21 08:00U:BSEMNews ReleaseBioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
2024-02-26 10:39U:BSEMNews ReleasePRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
2024-01-30 16:05U:BSEMNews ReleaseAmniowrap2 ¢ „ ¢ Product Launch Leads Year of Highlights for BioStem Technologies
2024-01-11 08:30U:BSEMNews ReleaseBioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
2023-12-19 08:30U:BSEMNews ReleaseBioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
2023-12-14 08:30U:BSEMNews ReleaseCenter for Medicare Services Established National Pricing of AmnioWrap2 ¢ „ ¢ ‚  in All MAC Regions
2023-12-13 08:30U:BSEMNews ReleaseBioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
2023-11-13 17:18U:BSEMNews ReleaseBioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
2023-11-08 08:31U:BSEMNews ReleaseBioStem Technologies Awarded Q Code for VENDAJE AC ‚ ® Line from Centers for Medicare and Medicaid Services
2023-11-06 08:32U:BSEMNews ReleaseBioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
2023-11-03 08:30U:BSEMNews ReleaseBioStem Technologies Closes Oversubscribed $2M Private Placement
2023-10-24 08:33U:BSEMNews ReleaseBioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
2023-10-17 12:11U:BSEMNews ReleaseBioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
2023-09-29 08:32U:BSEMNews ReleaseBioStem Technologies: CMS Decision a ¢ € œWin For Patients ¢ € 
2023-09-26 08:34U:BSEMNews ReleaseBioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers